{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:26Z","timestamp":1707524606926},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"DOI":"10.7759\/cureus.26865","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T23:29:31Z","timestamp":1657841371000},"source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of CML Blast Crisis and Severe COVID 19 Infection: A Case Report"],"prefix":"10.7759","author":[{"given":"Misbahuddin","family":"Khaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibha","family":"Hayagreev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ronderos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Siddiqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Moirangthem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen W","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin. 2016, 66:115-132. 10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030186","article-title":"Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks","volume":"4","author":"Ashour HM","year":"2020","unstructured":"Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020, 4:186. 10.3390\/pathogens9030186","journal-title":"Pathogens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01169-w","article-title":"What do we currently know about chronic myeloid leukemia (CML) and COVID-19?","volume":"24","author":"Delgado N","year":"2022","unstructured":"Delgado N, Torres A. What do we currently know about chronic myeloid leukemia (CML) and COVID-19?. Curr Oncol Rep. 2022, 24:645-650. 10.1007\/s11912-021-01169-w","journal-title":"Curr Oncol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China","volume":"6","author":"Yu J","year":"2020","unstructured":"Yu J, Ouyang W, Chua ML, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020, 6:1108-1110. 10.1001\/jamaoncol.2020.0980","journal-title":"JAMA Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira A","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020, 136:2881-2892. 10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94 Suppl 2","author":"Chereda B","year":"2015","unstructured":"Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015, 94 Suppl 2:S107-S121. 10.1007\/s00277-015-2325-z","journal-title":"Ann Hematol"},{"key":"ref7","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised","year":"2017","unstructured":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised. Swerdlow SH, Campo E, Harris NL, et al.  (ed). International Agency for Research on Cancer (IARC), Lyon; 2017."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage DG","year":"1997","unstructured":"Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol. 1997, 96:111-116. 10.1046\/j.1365-2141.1997.d01-1982.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000348681","article-title":"Sudden extramedullary blast crisis of chronic myeloid leukemia manifesting as T-cell lymphoblastic lymphoma","volume":"36","author":"Wei J","year":"2013","unstructured":"Wei J, Huang M, Wang Y, Zhou J. Sudden extramedullary blast crisis of chronic myeloid leukemia manifesting as T-cell lymphoblastic lymphoma. Onkologie. 2013, 36:119-122. 10.1159\/000348681","journal-title":"Onkologie"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25628","article-title":"Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin","volume":"94","author":"Lauseker M","year":"2019","unstructured":"Lauseker M, Bachl K, Turkina A, et al.. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. Am J Hematol. 2019, 94:1236-1243. 10.1002\/ajh.25628","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin Y","year":"2020","unstructured":"Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020, 12:372. 10.3390\/v12040372","journal-title":"Viruses"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0853-6","article-title":"COVID-19 in persons with chronic myeloid leukaemia","volume":"34","author":"Li W","year":"2020","unstructured":"Li W, Wang D, Guo J, et al.. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020, 34:1799-1804. 10.1038\/s41375-020-0853-6","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01132","article-title":"Management of chronic myeloid leukemia in advanced phase","volume":"25","author":"Bonifacio M","year":"2019","unstructured":"Bonifacio M, Stagno F, Scaffidi L, Krampera M, Di Raimondo F. Management of chronic myeloid leukemia in advanced phase. Front Oncol. 2019, 25:9. 10.3389\/fonc.2019.01132","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2020.2020.0472","article-title":"COVID-19 in chronic-phase chronic myeloid leukemia patients: a single-center survey from Turkey","volume":"38","author":"Y\u0131lmaz U","year":"2021","unstructured":"Y\u0131lmaz U, Pekmezci A, G\u00fcl Y, E\u015fkazan AE. COVID-19 in chronic-phase chronic myeloid leukemia patients: a single-center survey from Turkey. Turk J Haematol. 2021, 38:79-81. 10.4274\/tjh.galenos.2020.2020.0472","journal-title":"Turk J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30150-9","article-title":"Risk of COVID-19 for patients with cancer","volume":"21","author":"Xia Y","year":"2020","unstructured":"Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020, 21:e180. 10.1016\/S1470-2045(20)30150-9","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He W","year":"2020","unstructured":"He W, Chen L, Chen L, et al.. COVID-19 in persons with haematological cancers. Leukemia. 2020, 34:1637-1645. 10.1038\/s41375-020-0836-7","journal-title":"Leukemia"},{"key":"ref17","article-title":"A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of cancer and leukemia group B","volume":"15","author":"Dillman RO","year":"1991","unstructured":"Dillman RO, Davis RB, Green MR, et al.. A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of cancer and leukemia group B. Blood. 1991, 15:2520-2526.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers CL","year":"2002","unstructured":"Sawyers CL, Hochhaus A, Feldman E, et al.. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood. 2002, 99:3530-3539. 10.1182\/blood.v99.10.3530","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang X","year":"2020","unstructured":"Zhang X, Song K, Tong F, et al.. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 2020, 4:1307-1310. 10.1182\/bloodadvances.2020001907","journal-title":"Blood Adv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16901","article-title":"Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia","volume":"190","author":"Ranger A","year":"2020","unstructured":"Ranger A, Haji R, Kaczmarski R, Danga A. Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia. Br J Haematol. 2020, 190:e128-e130. 10.1111\/bjh.16901","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102830-co-occurrence-of-cml-blast-crisis-and-severe-covid-19-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:38Z","timestamp":1707507938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102830-co-occurrence-of-cml-blast-crisis-and-severe-covid-19-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.26865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}